Shanghai, China

Yaocheng Rui

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fudan University, Shanghai Bajiayi Pharmaceutical Science and Technology Co. Ltd.. Active years: 2013-2018.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yaocheng Rui: Innovator in Medical Technology

Introduction

Yaocheng Rui is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in the development of innovative treatments for cancer and myocardial ischemia. With a total of 2 patents, his work is paving the way for new therapeutic options.

Latest Patents

One of Yaocheng Rui's latest patents is focused on the application of cyclic dinucleotide (cGAMP) in the anti-tumor field. This invention demonstrates that cGAMP can inhibit the growth of various types of tumor cells, showcasing remarkable anti-tumor effects. The research indicates that cGAMP can be utilized in the preparation of anti-tumor drugs that exhibit low toxicity and favorable efficacy. In studies conducted using a subcutaneous tumor model in nude mice, cGAMP showed significant inhibition of tumors from several human cancer cell lines, including gastric carcinoma, lung adenocarcinoma, colorectal carcinoma, hepatocellular carcinoma, prostatic carcinoma, and pancreatic carcinoma. Additionally, cGAMP has been proven to have relatively low acute toxicity, making it a promising candidate for anti-tumor drug development.

Another notable patent involves a method for treating myocardial ischemia through the use of a polypeptide micromolecule known as MLIF. The amino acid sequence of this micromolecule is Met-Gln-Cys-Asn-Ser (SEQ ID NO:1). This invention aims to provide a new medicine for preventing and treating myocardial ischemia, highlighting Rui's commitment to advancing medical treatments.

Career Highlights

Yaocheng Rui has worked with esteemed institutions such as Fudan University and Shanghai Bajiayi Pharmaceutical Science and Technology Co. Ltd. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects in the medical field.

Collaborations

Throughout his career, Yaocheng Rui has collaborated with notable colleagues, including Tiejun Li and Yuefan Zhang. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Yaocheng Rui is a distinguished inventor whose work in medical technology is making a significant impact on the treatment of cancer and myocardial ischemia. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…